000			01437 a2200385 4500
005			20250514190015.0
264		0	_c20050502
008			200505s 0 0 eng d
022			_a1551-4005
040			_aNLM _beng _cNLM
100	1		_aMizenina, Olga A
245	0	0	_aS-phase inhibition of cell cycle progression by a novel class of pyridopyrimidine tyrosine kinase inhibitors. _h[electronic resource]
260			_bCell cycle (Georgetown, Tex.) _cJun 2004
300			_a796-803 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBreast Neoplasms _xenzymology
650	0	4	_aCDC2 Protein Kinase _xagonists
650	0	4	_aCDC2-CDC28 Kinases _xmetabolism
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Cycle Proteins _xantagonists & inhibitors
650	0	4	_aCell Line, Tumor
650	0	4	_aCyclin-Dependent Kinase 2
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aNuclear Proteins _xantagonists & inhibitors
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPyridines _xpharmacology
650	0	4	_aPyridones _xmetabolism
650	0	4	_aPyrimidines _xantagonists & inhibitors
650	0	4	_aS Phase _xphysiology
700	1		_aMoasser, Mark M
773	0		_tCell cycle (Georgetown, Tex.) _gvol. 3 _gno. 6 _gp. 796-803
999			_c14846259 _d14846259